Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs

Posted on June 2nd, 2017 by in Pharma R&D

Know the rules

Since 1906, the US Food and Drug Administration (FDA) through regulations has been responsible for ensuring the approval of new drugs whose health benefits outweigh the known risks associated with the drug.

Continue reading “FDA Regulations Reform? Risks and Benefit for the Approval Process of New Drugs” »

Predicting Adverse Event Risks and Gaining Insights from Disparate Data

Posted on May 17th, 2017 by in Pharma R&D

The upcoming Bio IT World Conference and Expo will feature two talks from Elsevier Life Sciences consultants, focusing on predicting adverse events in clinical trials and extracting knowledge from multiple data sets. Continue reading “Predicting Adverse Event Risks and Gaining Insights from Disparate Data” »

Making Precision Medicine a Reality

Posted on April 24th, 2017 by in Chemistry

Precision medicine is no longer just a promising new development discussed only by medical professionals and industry insiders at conferences and in journals. In early 2015, former U.S. President Barack Obama announced the $215 million Precision Medicine Initiative Continue reading “Making Precision Medicine a Reality” »

Lessons Learned from a Clinical Trial Failure

Posted on March 14th, 2017 by in Chemistry

Revisiting failed clinical trials is important because these studies may generate new insights into drug research and development, leading to effective new treatments. Researchers in the recent IMPROVE-IT trial learned valuable lessons from the failure of the earlier ENHANCE study Continue reading “Lessons Learned from a Clinical Trial Failure” »

  1. 1
  2. 2
  3. 3
  4. 4